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852-5 Wall Thickening Assessment With Tissue Harmonic 
Echocardiography Results in Improved Risk 
Stratification for Patients With Non-ST-Segment 
Elevation Acute Chest Pain 
Michael Hickman, Jonathan Swinbum, Roxy Senior, Northwick Park Hospital, Harrow, 
United Kingdom 
Background: The objective of this study was to demonstrate whether the improved 
imaging quality gained by using tissue harmonic echocardiography (THE) results in the 
improved risk stratification of patients presenting with non-ST-elevation acute chest pain. 
Risk stratification for acute chest pain is based upon clinical findings, electrocardio- 
graphic and cardiac enzyme analysis. Echocardiography has also been shown to be use- 
ful to risk stratify these patients by identifying or excluding wall motion abnormalities 
which is a marker of ischaemia. We hypothesised that THE, which enhances assess- 
ment of systolic wall thickening compared to fundamental echocardiography (FE), will 
result in improved risk stratifiation of acute chest pain. 
Methods: Eiahtv consentina oatients with over 30 minutes of non-ST-elevation chest 
pain that had-lasted less than’six hours were recruited. All patients were assessed and 
underwent restino THE and FE scans. Diaonosis of index acute mvccardial infarction 
(AMI) was madebn a 24 hour creatine k&e-MB sample. Echoca;diographic images 
were reported by two experienced blinded observers using a 14 segment model. Patients 
were followed up at least 4 months after admission. Endpoints included all-cause mortal- 
ity, non-fatal myocardial infarction and revascularisation procedures. 
Results: THE allowed assessment of all myocardial segments in all patients compared 
to 43/78 patients (p<O.OOi) with FE. Follow up lasted a mean of 224 days. During this 
period there were 33 adverse cardiac events affecting 29(36%) patients. A wall thicken- 
ing abnormality demonstrated on THE was a significant predictor of AMI on admission, 
x2=7.2, p.zO.007 and for an adverse cardiac event during follow up, x*=1 0.0, p=O.O02. A 
wall thickening abnormality demonstrated with FE was neither a significant predictor of 
AMI nor for an adverse cardiac event during follow up. 
Conclusions: Tissue harmonic echocardiography is superior to fundamental echocar- 
diography for accurate assessment of systolic wall thickening and hence nsk stratification 
for patients presenting with acute chest pain and non-diagnosable ECG changes. 
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852-6 Transthoracic Doppler Echocardiographic Assessment 
of lntramyocardial Artery Flow and Coronary Flow 
Velocity Pattern Predict Wall Motion Recovery 
Following Acute Myocardial Infarction 
Tomoko Tani, Kazuaki Tanabe, Motoaki Ibuki. Minako Katayama, Koichi Tamita, Kenji 
Yamabe. Atsushi Yamamuro. Kunihiko Naoai. Kenichi Shiratori. Shioefumi Morioka. 
Kobe General Hospital, Kobe. Japan ” 
Background: Previous study using a Doppler guide wire has reported that coronary flow 
velocity pattern (CFV) with a rapid diastolic deceleration time (DDT) immediately after 
percutaneous coronary intervention (PCI) implies the advanced microvascular damage in 
patients with acute myocardial infarction (AMI). Recent advances in transthoracic color 
Doppler echocardiography (TTCDE) provide coronary flow velocity measurement in the 
left anterior descending coronary artery (LAD) and flow velocity measurement of intramy- 
ocardial artery. We sought to investigate the relationship between CFV of LAD and 
intramyocardial artery in the infarcted area and wall motion recovery following AMI. Meth- 
ods: Using pulsed TTCDE (Logic 500, GE Yokogawa Medical), we recorded CFV of LAD 
and FV of intramyocardial artery in the antero-septal lesion 2 days after successful PCI in 
24 patients (pts) with anterior AMI. We measured DDT of LAD (DDTLAD) and DDT of 
intramyocardial artery (DDTmyo). Patients were divided into 2 groups according to wall 
motion recovery of the infarcted area 4 weeks after AMI (group A: 14 pts with wall motion 
recovers. wow 8: 10 ots with no wall motion recover). Results: DDTLAD was sianifi- 
cantly shorter in pts with group B than group A (249f1;2ms vs. 753+376ms. p=OTOl). 
DDTmvo was sianificantlv shorter in ots with wow B than orouo A (248*146ms vs. 
I , I  _ .  
768*309ms, p=O.O04). DDTLAD and maximal diastolic flow velocity (MDV) significantly 
correlated with DDTmyo (r=O.760, pcO.0001) and MDV of intramyccardial artery 
(r=O.631, p=O.OOOl), respectively. The optimal cutoff value was 730ms for DDTLAD 
(sensitivity 94%, specificity 60%) and 665ms for DDTmyo (sensitivity 66%, specificity 
79%) in predicting wall motion recovery. Conclusions: Microvascular damage might 
reflect diastolic flow velocity pattern of both LAD and intramyocardial artery. We could 
predict wall motion recovery of infarcted area by using CFV of LAD and FV of intramyo- 
cardial artery. 
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858-1 Effects of ACAT Inhibition by Positron Emission 
Tomography Measured Myocardial Blood Flow: A 
Double-Blind, Randomized, Multicenter Trial 
Heinrich Ft. Schelbert, Alita Hassan, Jennifer Gamer, Marcel0 F. DI Carli, UCLA School 
of Medicine, Los Angeles, CA, Pfizer Global Research and Development, Ann Arbor, Ml 
Purpose: Avasimibe, an oral acyl-CoA: cholesterol-O-acyltransferase (ACAT) inhibitor 
has demonstrated anti-atherosclerotic properties in animals. To determine whether ava- 
simibe beneficially affects the regional myocardial flow reserve (rMFR) in patients with 
documented or at risk for coronary artery disease (CAD). Methods: 327 patients (age 17 
to 75 years; 101 female) with a rMFR (2.5 were randomized to placebo plus atorvastatin 
10mg QD (atorva) or avasimibe 50 mg QD plus atorvastatin 1Omg QD (ava50, combina- 
tion) or avasimibe 750 mg QD plus atorvastatin 10 mg QD (ava750, combination). PET 
measured myocardial blood flows at rest and during adenosine stress at baseline and at 
54 weeks to determine rMFR pre and post treatment. Results: At baseline, rMFR was 
similar in the three groups (1.69*0.05 SE; 1.59eO.6 and 1.57+0.06: p=NS). At 54 weeks, 
rMFR had improved by 0.27;tO.ll (ArMFR) for atorva, by 0.40*0.10 for ava50 and by 
0.49+0.11 for ava750 combination therapy. The incremental, treatment-related ArMFR 
differences (over control) of 0.13 and of 0.22 between ava50 and ava750-combination 
and the atolva control group, while favoring avasimibe, were statistically not significant 
(p=O.26 and p=O.13). Defining a t 20% rMFR increase as a positive response, more 
patients responded to ava50 and to ava750-combination than to atorva (36% and 44%; 
respectively vs. 27%; p=O.Ol ava750 vs. atorva). Conclusions: The observed trend of a 
greater rMFR increase in the combination than in atorva patients, though statistically not 
significant, together with a significantly higher incidence of positive rMFR responses in 
the avasimibe treatment group suggest a possible “beneficial” anti-atherosclerotic effect 
of avasimibe in patients with documented or at risk for CAD. 
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858-2 Caffeine Decreases Coronary Flow Reserve at Exercise 
in Healthy Volunteers 
Mehdi Namdar, Renate Grathwohl, Raphael Delaloye. Pascal Koepfli. Philipp A. 
Kaufmann, University Hospital, Zurich, Switzerland 
Background: Caffeine antagonizes adenosine-induced hyperemic myocardial blood 
flow (MBF).lts impact on exercise-induced coronary flow reserve (CFR)remains 
unknown. 
Aim: To determine the acute effect of caffeine on CFR during bicycle exercise at base- 
line and during exposure to simulated altitude. 
Methods: 150-labelled H20 and Positron Emission Tomography (PET) was used to 
measure CFR in 16 healthy volunteers (mean age 26 * lyr ) before and 50 minutes after 
oral ingestion of caffeine (200mg). Supine bicycle exercise (mean workload 154 Watts, 
100% of predicted) was used as stress. Measurements were performed at normoxia 
(n=6) or during simulation of an altitude of 4500m by inhalation of 12.5 % oxygen in N2 
(n=6). 
Results: Caffeine levels were zero at baseline in all subjects and increased to 14.7 f 2 
mmoll fifty minutes after caffeine intake. Rate pressure product (rest and exercise) was 
not affected by caffeine. Caffeine increased resting MBF significantly by 21+16% (nor- 
moxia; p<O.O005) and 35i15% (hypoxia), whereas hyperemic MBF decreased signifi- 
cantly by 17*18% (normoxia; p<O.O005) and 25+11% (hypoxia; p<O.O005), resulting in a 
decrease in CFR of 24% (normoxia) and 47% (normoxia). 
Conclusions: Intake of a caffeine dose equivalent to two cups of coffee significantly 
reduces CFR during physical exercise. This effect is even more pronounced at exposure 
to simulated high altitude, suggesting that caffeine may antagonize intrinsic adenosine 
mediated hyperemic response to exercise and hypoxia. 
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